Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Qualigen Therapeutics Inc (NQ: QLGN )

1.010 UNCHANGED
Streaming Delayed Price Updated: 3:57 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.010
Bid (Size) 0.9652 (17)
Ask (Size) 1.040 (165)
Prev. Close 1.010
Today's Range 1.010 - 1.010
52wk Range 0.9300 - 15.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
-26.81%
-26.81%
1 Month
-17.21%
-17.21%
3 Month
-24.31%
-24.31%
6 Month
-64.03%
-64.03%
1 Year
-84.70%
-84.70%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced Solid Tumors
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Qualigen Therapeutics Announces Two Posters of Its RAS-Targeted Inhibitor Program at the National Cancer Institute
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
Qualigen Therapeutics to Present at LD Micro Main Event XV
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket
Via Benzinga
Qualigen Therapeutics to Present Two Posters at the National Cancer Institute Fourth RAS Initiative Symposium
From Qualigen Therapeutics, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.